EIF2A and non-small cell lung carcinoma: We also previously demonstrated that PKR and its downstream protein, phosphorylated eIF2α (p-eIF2α), are independent prognostic markers for overall survival in patients with non-small cell lung cancer (NSCLC) [10, 11].